Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Gastric Motility
Interventions
DRUG

Relamorelin

Double blind RM-131 will be delivered three times by injection during the course of the study

DRUG

Placebo

Double blind Placebo will be delivered three times by injection during the course of the study

Trial Locations (1)

Unknown

Mayo Clinic - Rochester, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Motus Therapeutics, Inc.

INDUSTRY